Xhosa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write
Iindidi zeendaba
Iindaba Eziphambili
Unyango lwe-BioOCUS Medical Group's Dual CD19/BCMA CAR-T luzisa iziphumo ezithembisayo kwi-Refractory Myasthenia Gravis: Uhambo lwesigulana esiselula

Amaqela amabini eBIOOCUS Medical Group...
Isigulana sase-Australia Sifumana Impendulo Emangalisayo Kwangoko nge-BIOOCUS Medical Group's Dual CD19/CD20 CAR-T Therapy ye-DLBCL ephinde yabuyela kwi-DLBCL

Isigulana sase-Australia Siphumelele...
Ukubaluleka Kokulandelelana Rhoqo Nokuhlolwa Emva Kokufakelwa Kweeseli Ze-Hematopoietic Stem

Ukubaluleka kwe-F Rhoqo ...
Unyango lwe-CAR-T Loyisa Ukuqikelela Okubi kwi-B-Cell Lymphoma ePhakamileyo

Unyango lwe-CAR-T Loyisa Ubumdaka...
Ukungenelela Kwangoko Nge-CAR-T Therapy Kwi-B-Cell Lymphoma Enkulu Kubonisa Iziphumo Ezithembisayo

Ukungenelela Kwangoko kwi-CAR...
Unyango lwe-CAR-T lubonisa ukhuseleko kunye nokusebenza kakuhle kwizigulane zomhlaza ezinezifo ezizikhuselayo okanye ezibangela ukudumba

Unyango lwe-CAR-T lubonisa ukhuseleko ...
Ukuqonda okutsha kwiintlobo zezakhi zofuzo zabantu abadala i-B-ALL

Ulwazi oluphambili malunga...
Uphononongo oluPhambili luqinisekisa uKhuseleko kunye nokusebenza kakuhle koNyango lwe-CD19/CD20 CAR-T kwi-r/r B-NHL

Uphononongo oluPhambili Luyaqinisekisa...
Ii-Biomarkers ezintsha ziqikelela iziphumo zonyango lwe-CAR-T kunyango lwe-Multiple Myeloma

Ii-Biomarkers ezintsha ziqikelela i-CAR-...
Unyango lwe-CAR-T: Ikamva Elithembisayo Leengxaki Zeeseli ze-T

Unyango lwe-CAR-T: Ithemba ...
0102030405

Ilizwi laseTshayina le-ASH| UNjingalwazi uXian Zhang: Ukusebenza Okuphezulu Nokhuseleko Lonyango lwe-Nanobody Anti-BCMA CAR-T olusekwe kwi-Nanobody ekunyangeni izigulana ezine-Myeloma ephindaphindeneyo okanye enokurhawuzelelwa

2024-04-09

ASH Voice of China.jpg

Intlanganiso Yonyaka yama-65 ye-American Society of Hematology (ASH) ibibanjwe ukususela nge-9 ukuya kwi-12 kaDisemba 2023, eSan Diego, e-USA. Njengomsitho wezemfundo omkhulu nowona ubanzi we-hematology, itsala amawaka eengcali kunye neengcali ezivela kwihlabathi liphela minyaka le ukuze babelane ngenkqubela phambili ye-hematology yanamhlanje kunye nedatha yeklinikhi ebalaseleyo. KwiNgqungquthela ye-ASH yalo nyaka, uphando lukaNjingalwazi uXian Zhang weSibhedlele saseLu Dao Pei lukhethwe ukuba luboniswe ngomlomo (Isishwankathelo No. 2107), oluphande ukusebenza kakuhle kunye nokhuseleko lonyango lwe-anti-BCMA CAR-T olusekelwe kwi-nanobody ekunyangeni izigulana ezine-relapse okanye ezingenakukwazi ukujongana nalo mbandela. I-Multiple Myeloma.